Novozymes-Chr. Hansen merger decision shows EU’s focus on innovation
EU regulators are under pressure to give more leeway to companies to merge to gain scale, which would allow them to innovate. But a decision published this week on Novozymes’ merger with...To view the full article, register now.
Already a subscriber? Click here to view full article